your market intelligence analyst
Search Results
362 results
Your search is now limited to «Roche» expert search. 06/04/2020 01:31
Roche test receives FDA emergency use approval for COVID-19 patients.
More from 06/04/2020 01:15
Roche test receives FDA emergency use approval for COVID-19 patients.
More from
Hoffmann-La Roche (EU) 06/04/2020 01:00
Roche’s Elecsys IL-6 test receives FDA Emergency Use Authorisation to help in identifying patients at high risk of severe inflammatory response.
More from Hoffmann-La Roche (EU):
ETHealthWorld (India) 06/03/2020 09:08
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
More from ETHealthWorld (India):
Benzinga 06/02/2020 07:45
Here's a roundup of top developments in the biotech space over the last 24 hours:. Scaling The Peaks. (Biotech Stocks Hitting 52-week Highs June 1). Adaptimmune Therapeutics PLC – ADR (NASDAQ: ). Aileron Therapeutics Inc (NASDAQ: ) (announced positive interim results for its Phase 1b/2 study of ALRN-6924 as an agent to protect patients against chemotherapy-induced toxicity). argenx SE – ADR (NASDAQ: ). Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: ). Cerus Corporation (NASDAQ: ). Dynavax Technologies Corporation (NASDAQ: ) (reacted to reports of partner Sinovac expressing confidence in its coronavirus vaccine). Emergent Biosolutions Inc (NYSE: ) (announced $628-million dollar BARDA funding for rapid development of COVID-19 vaccine candidate.
More from Benzinga:
GlobeNewswire 06/02/2020 01:00
About Roche in cancer immunotherapy Roche’s rigorous pursuit of groundbreaking science has contributed to major therapeutic and diagnostic advances in oncology over the last 50 years, and today, realising the full potential of cancer immunotherapy is a major area of focus ...
More from GlobeNewswire:
Homeland Preparedness News 06/01/2020 08:15
As more information about COVID-19 pneumonia becomes available in these unprecedented times, it is more important than ever to work together to fight this disease,” said Dr. Levi Garraway, Roche’s chief medical officer and head of Global Product Development.
More from Homeland Preparedness News:
Motley Fool 05/30/2020 07:44
They're both leaders in COVID-19 diagnostics testing and a whole lot more. But one stock appears to be the better pick right now.
More from Motley Fool:
RTT News 05/30/2020 06:41
The week that just passed by saw some big names joining the race to develop vaccines for COVID-19, a couple of deals to speed up the manufacture of the vaccine and promising trial results of one of the potential COVID-19 treatments.
More from RTT News:
FiercePharmaManufacturing 05/29/2020 15:30
Roche's Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod.
More from FiercePharmaManufacturing:
PMLiVE 05/29/2020 08:20
Roche and Gilead Sciences are joining forcers to fight COVID-19 with a 450-patient trial that will combine two drugs already being tested against coronavirus as monotherapies.
More from PMLiVE:
Business Wire 05/29/2020 08:00
Our initial neurology program with Roche continues to make great progress and we hope to assist Roche in bringing multiple meaningful therapies to patients in areas of neurological disease with major unmet needs through both our initial and this new program.
More from Business Wire:
Roche has announced the commencement of phase III clinical study of Actemra/RoActemra plus remdesivir in hospitalised patients with severe Covid-19 pneumonia.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications